Skip to Content

9 Results Found

  • Article
  • Open Access
21 Citations
7,510 Views
15 Pages

Development and Characterization of an Amorphous Solid Dispersion of Furosemide in the Form of a Sublingual Bioadhesive Film to Enhance Bioavailability

  • Viviana De Caro,
  • Alessia Ajovalasit,
  • Flavia Maria Sutera,
  • Denise Murgia and ,
  • Maria Antonietta Sabatino and
  • Clelia Dispenza
  • + 1 author+ 0 author

Administered by an oral route, Furosemide (FUR), a diuretic used in several edematous states and hypertension, presents bioavailability problems, reported as a consequence of an erratic gastrointestinal absorption due to various existing polymorphic...

  • Article
  • Open Access
60 Citations
12,080 Views
16 Pages

BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide

  • Milica Markovic,
  • Moran Zur,
  • Inna Ragatsky,
  • Sandra Cvijić and
  • Arik Dahan

Biopharmaceutical classification system (BCS) class IV drugs (low-solubility low-permeability) are generally poor drug candidates, yet, ~5% of oral drugs on the market belong to this class. While solubility is often predictable, intestinal permeabili...

(This article belongs to the Special Issue Regional Intestinal Drug Absorption: Biopharmaceutics and Drug Formulation)
  • Article
  • Open Access
11 Citations
5,692 Views
13 Pages

Furosemide/Non-Steroidal Anti-Inflammatory Drug–Drug Pharmaceutical Solids: Novel Opportunities in Drug Formulation

  • Francisco Javier Acebedo-Martínez,
  • Carolina Alarcón-Payer,
  • Lucía Rodríguez-Domingo,
  • Alicia Domínguez-Martín and ,
  • Jaime Gómez-Morales and
  • Duane Choquesillo-Lazarte
  • + 1 author+ 0 author

2 November 2021

The design of drug–drug multicomponent pharmaceutical solids is one the latest drug development approaches in the pharmaceutical industry. Its purpose is to modulate the physicochemical properties of active pharmaceutical ingredients (APIs), most of...

(This article belongs to the Special Issue Multicomponent Pharmaceutical Solids)
  • Article
  • Open Access
12 Citations
5,786 Views
9 Pages

25 November 2017

Furosemide loaded electrospun fibers were prepared for buccal administration, with the aim of improving the oral bioavailability of the poorly soluble and permeable crystalline drug, which can be achieved by the increased solubility and by the circum...

(This article belongs to the Special Issue Advances in Mucoadhesive Polymers and Formulations for Transmucosal Drug Delivery)
  • Article
  • Open Access
7 Citations
1,341 Views
20 Pages

Exploring the Potential of Cellulose Nanocrystals Originated from Ramie (Boehmeria nivea L. Gaud) in Formation of Microspheres for Enhanced Solubility of Furosemide

  • Anis Yohana Chaerunisaa,
  • Yoga Windhu Wardhana,
  • Mayang Kusuma Dewi,
  • Margaretha Efa Putri and
  • Fitriani Jati Rahmania

5 July 2025

Cellulose nanocrystals possess unique properties such as high surface area and excellent biocompatibility. They can disrupt strong hydrogen bonds and other intermolecular forces that hinder the solubility of certain molecules thus enhancing the solub...

(This article belongs to the Section Polymer Applications)
  • Communication
  • Open Access
3 Citations
8,666 Views
9 Pages

Polyols Permeability on Caco-2 Cells and Their Effects on Transport of Low-Permeability Drugs

  • Damien Truffin,
  • Olaf Häusler,
  • Maryse Martin,
  • Sandrine Cotier and ,
  • Jerôme Laparre and
  • Manilduth Ramnath
  • + 1 author+ 0 author

Some pharmaceutical excipients are able to modify intestinal permeability, thus influencing drug absorption and bioavailability. The effect of four polyols (mannitol, maltitol, sorbitol and xylitol) on the permeability of seven active pharmaceutical...

  • Article
  • Open Access
51 Citations
12,930 Views
15 Pages

The Effect of the Particle Size Reduction on the Biorelevant Solubility and Dissolution of Poorly Soluble Drugs with Different Acid-Base Character

  • Dóra Csicsák,
  • Rita Szolláth,
  • Szabina Kádár,
  • Rita Ambrus and ,
  • Csilla Bartos,
  • Emese Balogh,
  • István Antal,
  • István Köteles,
  • Petra Tőzsér and
  • Gergely Völgyi
  • + 10 authors+ 5 authors

Particle size reduction is a commonly used process to improve the solubility and the dissolution of drug formulations. The solubility of a drug in the gastrointestinal tract is a crucial parameter, because it can greatly influence the bioavailability...

(This article belongs to the Section Physical Pharmacy and Formulation)
  • Article
  • Open Access
11 Citations
3,802 Views
13 Pages

Poor and variable oral bioavailability of furosemide (FUR) presents critical challenges in pharmacotherapy. We investigated the interplay of breast cancer resistance protein (Bcrp)-mediated transport, sex, and fed state on FUR pharmacokinetics (PK) i...

(This article belongs to the Special Issue Role of Pharmacokinetics in Drug Development and Evaluation)
  • Article
  • Open Access
9 Citations
4,009 Views
19 Pages

Furosemide (FUR) is a diuretic used to relieve edema, congestive heart failure, cirrhosis, end-stage renal disease, and hypertension. FUR is a class IV according to the Biopharmaceutics Classification System. It is practically insoluble in water. Thi...

(This article belongs to the Special Issue Nanomaterials for Drug Targeting and Drug Delivery)